Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Ein echter Gamechanger: Diese News kann den Grundstein für eine Neubewertung der Rock-Tech-Aktie legen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EFB5 | ISIN: CH1251125998 | Ticker-Symbol: V6M
Frankfurt
26.06.25 | 09:08
2,270 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RELIEF THERAPEUTICS HOLDING AG Chart 1 Jahr
5-Tage-Chart
RELIEF THERAPEUTICS HOLDING AG 5-Tage-Chart

Aktuelle News zur RELIEF THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.06.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD0114.088Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 20-Jun-2025 / 07:00 CET/CEST Release of an ad hoc announcement...
► Artikel lesen
12.06.Relief Therapeutics Holding SA: Relief Therapeutics Announces Results of Annual General Meeting325Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Announces Results of Annual General Meeting 12.06.2025 / 11:00 CET/CEST Relief Therapeutics Announces...
► Artikel lesen
RELIEF THERAPEUTICS Aktie jetzt für 0€ handeln
22.05.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD0114.788Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 22-May-2025 / 07:00 CET/CEST Release of...
► Artikel lesen
15.05.Relief Therapeutics Holding SA: Relief Therapeutics Publishes 2025 Annual General Meeting Agenda481Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Publishes 2025 Annual General Meeting Agenda 15.05.2025 / 07:00 CET/CEST Relief Therapeutics Publishes...
► Artikel lesen
02.05.XFRA NEW INSTRUMENTS AVAILABLE ON 02.05.20256.519The following instruments on XETRA do have their first trading 02.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.05.2025 Aktien 1 CH0432492467 Alcon AG 2U3 2 CH0110240600...
► Artikel lesen
10.04.Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B7
10.04.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update1.325Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update 10-Apr-2025 / 07:00 CET/CEST Release of an...
► Artikel lesen
07.03.Relief Therapeutics and Renexxion terminate merger talks4
06.03.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion6.311Relief Therapeutics Holding SA / Key word(s): Merger Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion 06-March-2025 / 07:00 CET/CEST Release of an ad hoc announcement...
► Artikel lesen
11.02.Relief Therapeutics to get European patent for investigational drug RLF-TD01119
11.02.Relief Therapeutics Holding SA: Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011616Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 11.02.2025 / 07:00 CET/CEST Relief...
► Artikel lesen
22.01.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US4.259Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US 22-Jan-2025 / 07:00 CET/CEST Release of...
► Artikel lesen
27.12.24Relief Therapeutics Holding SA: Relief Therapeutics Provides Update on Potential Transaction with Renexxion781Relief Therapeutics Holding SA / Key word(s): Merger Relief Therapeutics Provides Update on Potential Transaction with Renexxion 27.12.2024 / 07:00 CET/CEST Relief Therapeutics...
► Artikel lesen
16.12.24Relief Therapeutics Holding SA: Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial531Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial 16.12.2024 / 07:00 CET/CEST Relief...
► Artikel lesen
13.12.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations10.599Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations 13-Dec-2024 / 23:00 CET/CEST Release...
► Artikel lesen
11.11.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa3.966Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa 11-Nov-2024 / 07:00...
► Artikel lesen
04.11.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger3.011Relief Therapeutics Holding SA / Key word(s): Merger Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger 04-Nov-2024 / 07:00 CET/CEST Release of an...
► Artikel lesen
29.10.24Relief Therapeutics Holding SA: Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE495Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE 29.10.2024 / 07:00 CET/CEST Relief...
► Artikel lesen
25.10.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents4.722Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents 25-Oct-2024 / 07:00 CET/CEST Release...
► Artikel lesen
21.10.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment3.151Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment 21-Oct-2024...
► Artikel lesen
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1